BBDC Venture Capital helps Canadian entrepreneurs by acting as a lender, investor, and advisor, focusing on small and medium-sized businesses that drive the economy. It provides financing, equity investments, and advice to fill gaps left by private banks, especially in knowledge-based industries, exporters, and underserved groups such as women and Indigenous entrepreneurs. Its product mix includes loans and venture-capital investments, with online application and other support services. Unlike banks that lend based on collateral alone, BDC combines funding with expertise and guidance to help businesses grow, scale, and succeed. The goal is to be a financially self-sustaining Crown corporation that strengthens Canada's economy by supporting entrepreneurship with capital and knowledge, while promoting social and environmental performance as certified through B Corp."}ിച്ച്(training) -> end
Work here?Claim your company
Industries
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
$8.3B
Headquarters
Montreal, Canada
Founded
1944
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$8.3B
Above
Industry Average
Funded Over
0 Rounds
CES Energy Solutions Corp. has amended and extended its credit facility, raising its total size to about C$750.0 million from C$550.0 million. The agreement is dated November 6, 2026, and the facility matures on November 6, 2031. The Bank of Nova Scotia leads the syndicate. It includes The Toronto-Dominion Bank, Bank of Montreal, ATB Financial, National Bank of Canada, Wells Fargo Bank, Royal Bank of Canada, and Business Development Bank of Canada. The deal includes a C$702.0 million revolving facility, a C$20.0 million Canadian operating facility, and a $20.0 million US operating facility. It also has a C$350.0 million accordion feature and drops the Total Net Debt to EBITDA covenant. "The new five-year term locks in current attractive terms," said chief financial officer Anthony Aulicino.
Learn more about how Relogix has completed $4 million in series A funding.
Specific Biologics, a Toronto gene-editing company, has closed an oversubscribed $35 million Series A round. Hatteras Venture Partners led it, with existing investors Lumira Ventures and adMare BioInnovations joining. New backers include Genesys Capital, the Business Development Bank of Canada's Life Sciences Venture Fund, DeepWork Capital, and Seido Capital. The money will take its lead Dualase® candidate through early clinical biomarker proof-of-concept in an adaptive Phase I/II trial. The trial targets patients with C9ORF72-associated amyotrophic lateral sclerosis (ALS), a disease with no approved therapies. Dualase® is designed to remove the DNA repeat expansions behind the disease. Such expansions are implicated in more than 40 genetic disorders.
Irréversible has closed a pre-seed financing round led by Quantacet to accelerate product development and expand its core engineering team.
BDC, Canada's development bank, launched Mission AI and AI Studio on November 2, 2026, two entrepreneur-led initiatives meant to put AI to work for business owners. Mission AI, led by Dominic Gagnon, will match small and medium-sized businesses (SMEs) with Canadian AI tools. A panel of entrepreneurs will test them in real businesses. BDC says 69% of Canadian SMEs rarely or never use AI, and only 5% are AI leaders. AI Studio, led by technology entrepreneur Raff Paquin, will build tools to simplify BDC's processes and help clients get financing faster. As of September 2026, BDC is invested in over 300 Canadian AI companies, totalling nearly $800 million.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
$8.3B
Headquarters
Montreal, Canada
Founded
1944
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs